Cargando…

Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer

BACKGROUND: To assess the impact of PET/CT functional parameters on survival, locoregional, and distant failure according to the most distant level of lymph node [(18)F]FDG uptake in patients with locally advanced cervical cancer (LACC). METHODS: Retrospective study including 148 patients with LACC...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Alejandra, Chantalat, Elodie, Angeles, Martina Aida, Ferron, Gwénaël, Ducassou, Anne, Daix, Manon, Attal, Justine, Bétrian, Sarah, Lusque, Amélie, Gabiache, Erwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308355/
https://www.ncbi.nlm.nih.gov/pubmed/35870900
http://dx.doi.org/10.1186/s12885-022-09785-w
_version_ 1784752967462682624
author Martinez, Alejandra
Chantalat, Elodie
Angeles, Martina Aida
Ferron, Gwénaël
Ducassou, Anne
Daix, Manon
Attal, Justine
Bétrian, Sarah
Lusque, Amélie
Gabiache, Erwan
author_facet Martinez, Alejandra
Chantalat, Elodie
Angeles, Martina Aida
Ferron, Gwénaël
Ducassou, Anne
Daix, Manon
Attal, Justine
Bétrian, Sarah
Lusque, Amélie
Gabiache, Erwan
author_sort Martinez, Alejandra
collection PubMed
description BACKGROUND: To assess the impact of PET/CT functional parameters on survival, locoregional, and distant failure according to the most distant level of lymph node [(18)F]FDG uptake in patients with locally advanced cervical cancer (LACC). METHODS: Retrospective study including 148 patients with LACC treated with concurrent chemoradiotherapy after PET/CT and para-aortic lymph node (PALN) surgical staging. Two senior nuclear medicine physicians reviewed all PET/CT exams and retrieved tumor and lymph node metabolic parameters: SUVmax, MTV, TLG. Oncological outcomes according to metabolic parameters and level of lymph node spread on PET/CT were assessed. RESULTS: In patients without lymph node uptake on PET/CT, high MTV values of the cervical tumor were associated with DFS (HR = 5.14 95%CI = [2.15–12.31]), OS (HR = 6.10 95%CI = [1.89–19.70]), and time to distant (HR = 4.73 95%CI = [1.55–14.44]) and locoregional recurrence (HR = 5.18 95%CI = [1.72–15.60]). In patients with pelvic lymph node (PLN) uptake but without PALN uptake on [(18)F]FDG-PET/CT, high MTV values of the cervical tumor were associated with DFS (HR = 3.17 95%CI = [1.02–9.83]) and OS (HR = 3.46 95%CI = [0.96–12.50]), and the number of PLN fixations was associated with DFS (HR = 1.30 95%CI = [1.10–1.53]), OS (HR = 1.35 95%CI = [1.11–1.64]), and time to distant (HR = 1.35 95%CI = [1.08–1.67]) and locoregional recurrence (HR = 1.31 95%CI = [1.08–1.59]). There was no significant association between cervical tumor metabolic or lymph node metrics and survival outcome in patients with PALN uptake. CONCLUSIONS: Cervical MTV is more accurate than SUVmax to predict survival outcome in patients with locoregional disease confined to the pelvis and should be implemented in routine clinical practice. Prognostic value of metabolic metrics disappears with PALN uptake, which is associated with distant failure in nearly half of patients. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9308355
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93083552022-07-24 Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer Martinez, Alejandra Chantalat, Elodie Angeles, Martina Aida Ferron, Gwénaël Ducassou, Anne Daix, Manon Attal, Justine Bétrian, Sarah Lusque, Amélie Gabiache, Erwan BMC Cancer Research Article BACKGROUND: To assess the impact of PET/CT functional parameters on survival, locoregional, and distant failure according to the most distant level of lymph node [(18)F]FDG uptake in patients with locally advanced cervical cancer (LACC). METHODS: Retrospective study including 148 patients with LACC treated with concurrent chemoradiotherapy after PET/CT and para-aortic lymph node (PALN) surgical staging. Two senior nuclear medicine physicians reviewed all PET/CT exams and retrieved tumor and lymph node metabolic parameters: SUVmax, MTV, TLG. Oncological outcomes according to metabolic parameters and level of lymph node spread on PET/CT were assessed. RESULTS: In patients without lymph node uptake on PET/CT, high MTV values of the cervical tumor were associated with DFS (HR = 5.14 95%CI = [2.15–12.31]), OS (HR = 6.10 95%CI = [1.89–19.70]), and time to distant (HR = 4.73 95%CI = [1.55–14.44]) and locoregional recurrence (HR = 5.18 95%CI = [1.72–15.60]). In patients with pelvic lymph node (PLN) uptake but without PALN uptake on [(18)F]FDG-PET/CT, high MTV values of the cervical tumor were associated with DFS (HR = 3.17 95%CI = [1.02–9.83]) and OS (HR = 3.46 95%CI = [0.96–12.50]), and the number of PLN fixations was associated with DFS (HR = 1.30 95%CI = [1.10–1.53]), OS (HR = 1.35 95%CI = [1.11–1.64]), and time to distant (HR = 1.35 95%CI = [1.08–1.67]) and locoregional recurrence (HR = 1.31 95%CI = [1.08–1.59]). There was no significant association between cervical tumor metabolic or lymph node metrics and survival outcome in patients with PALN uptake. CONCLUSIONS: Cervical MTV is more accurate than SUVmax to predict survival outcome in patients with locoregional disease confined to the pelvis and should be implemented in routine clinical practice. Prognostic value of metabolic metrics disappears with PALN uptake, which is associated with distant failure in nearly half of patients. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-07-23 /pmc/articles/PMC9308355/ /pubmed/35870900 http://dx.doi.org/10.1186/s12885-022-09785-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Martinez, Alejandra
Chantalat, Elodie
Angeles, Martina Aida
Ferron, Gwénaël
Ducassou, Anne
Daix, Manon
Attal, Justine
Bétrian, Sarah
Lusque, Amélie
Gabiache, Erwan
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer
title Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer
title_full Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer
title_fullStr Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer
title_full_unstemmed Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer
title_short Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer
title_sort metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308355/
https://www.ncbi.nlm.nih.gov/pubmed/35870900
http://dx.doi.org/10.1186/s12885-022-09785-w
work_keys_str_mv AT martinezalejandra metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT chantalatelodie metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT angelesmartinaaida metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT ferrongwenael metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT ducassouanne metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT daixmanon metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT attaljustine metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT betriansarah metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT lusqueamelie metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer
AT gabiacheerwan metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer